Gilead CEO O'Day vests 8,779 RSUs, withholds shares

Gilead Sciences, Inc. Chairman & CEO Daniel Patrick O'Day reported the vesting and settlement of 8,779 restricted stock units into an equal number of common shares on June 10, 2026.

Rhea-AI Filing Summary

Gilead Sciences, Inc. Chairman & CEO Daniel Patrick O'Day reported the vesting and settlement of 8,779 restricted stock units into an equal number of common shares on June 10, 2026. In connection with this vesting, 4,213 shares of common stock were withheld at $121.4800 per share to satisfy tax obligations. Following these transactions, he directly held 622,133 shares of Gilead common stock, and 92,080 restricted stock units were reported as outstanding.

Insider Trade Summary

8,779 shares exercised/converted

Exercise 3 txns

Insider O'Day Daniel Patrick

Role Chairman & CEO

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	8,779	$0.00	$0.00
Exercise	Common Stock	8,779	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	4,213	$121.48	$512K

Holdings After Transaction: Restricted Stock Unit — 92,080 contracts (Direct); Common Stock — 622,133 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
2. F2. The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

Key Figures

RSUs vested and converted: 8,779 shares Shares withheld for taxes: 4,213 shares Tax withholding price: $121.4800 per share +2 more

5 metrics

RSUs vested and converted 8,779 shares Restricted Stock Units converted into common stock on June 10, 2026

Shares withheld for taxes 4,213 shares Common shares withheld at $121.4800 per share for tax obligations

Tax withholding price $121.4800 per share Per-share value used for the tax-withholding disposition

Post-transaction common stock holdings 622,133 shares Direct Gilead common stock held by Daniel Patrick O'Day after the transactions

Remaining restricted stock units 92,080 units Restricted Stock Units reported as outstanding after the derivative transaction

Key Terms

Restricted Stock Unit, tax-withholding disposition, vesting schedule

3 terms

Restricted Stock Unit financial

"Each restricted stock unit represents the contingent right to receive one share"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

tax-withholding disposition financial

"transaction_action: tax-withholding disposition for Common Stock"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

vesting schedule financial

"The restricted stock units have a four-year vesting schedule"

A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did GILD's CEO Daniel O'Day report on June 10, 2026?

Daniel O'Day reported the vesting of 8,779 restricted stock units into common stock and a related tax-withholding transaction of 4,213 shares on June 10, 2026. These entries reflect equity compensation settlement rather than open-market purchases or sales.

How many GILD common shares does Daniel O'Day hold after this Form 4?

After the reported transactions, Daniel O'Day directly holds 622,133 shares of Gilead common stock. This figure reflects his post-transaction ownership reported in the filing’s holdings table and includes the newly vested shares net of tax-withholding.

What happened to the 8,779 restricted stock units reported by GILD's CEO?

The 8,779 restricted stock units vested and were settled into an equal number of Gilead common shares. Each unit represents a contingent right to one share, subject to the award’s four-year vesting schedule described in the accompanying footnotes.

Why were 4,213 GILD shares disposed of in Daniel O'Day's Form 4?

The 4,213 common shares were disposed of as a tax-withholding transaction at $121.4800 per share. They were delivered to cover tax obligations arising from the vesting of restricted stock units, not as a discretionary market sale.

How many restricted stock units remain outstanding for GILD's CEO after these transactions?

After the reported vesting event, 92,080 restricted stock units were reported as outstanding for Daniel O'Day. These units follow a four-year vesting schedule, with portions vesting over time according to the grant’s terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/11/2026 - 06:29 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Day Daniel Patrick

(Last) (First) (Middle)

333 LAKESIDE DRIVE

(Street)

FOSTER CITY CALIFORNIA 94404

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GILEAD SCIENCES, INC. [ GILD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		M		8,779	A	(1)	626,346	D
Common Stock	06/10/2026		F		4,213	D	$121.48	622,133	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	06/10/2026		M			8,779	(2)	(2)	Common Stock	8,779	(1)	92,080	D

Explanation of Responses:

1. Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

2. The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

Remarks:

	/s/ Amy Kim by Power of Attorney for Daniel O'Day	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)